期刊文献+

碳青霉烯类耐药肺炎克雷伯菌药物敏感性及bla_(KPC)基因检出率 被引量:18

Susceptibility and prevalence of bla_(KPC) gene in carbapenem-resistant Klebsiella pneumoniae
下载PDF
导出
摘要 目的了解复旦大学附属华山医院碳青霉烯类耐药肺炎克雷伯菌(carbapenem-resistant Klebsiella pneumoniae,CRKP)对常用抗菌药物的敏感性及bla_(KPC)基因的检出率。方法收集2014年1-12月临床分离的CRKP,微量肉汤稀释法测定CRKP对常用抗菌药物的敏感性;聚合酶链反应(PCR)扩增bla_(KPC)基因。结果共收集CRKP 205株,主要分离自呼吸道标本(76.1%,156/205)和尿标本(18.5%,38/205)。药敏试验结果显示,CRKP对大多数抗菌药物高度耐药,除对多黏菌素E、替加环素、甲氧苄啶-磺胺甲唑和阿米卡星的耐药率分别为1.5%、0.5%、51.0%和74.9%外,对其他抗菌药物的耐药率在85%~100%;87.8%(180/205)菌株为blaKPC基因阳性株。结论 CRKP对多黏菌素和替加环素之外的多数临床常用抗菌药物呈高度耐药;产KPC型碳青霉烯酶是CRKP对碳青霉烯类耐药最主要的耐药机制。 Objective To examine the antimicrobial susceptibility and prevalence of blaKPC gene in carbapenem-resistant Klebsiella pneumoniae (CRKP) strains isolated in Huashan Hospital, Fudan University. Methods The CRKP strains isolated in Huashan Hospital from January to December of 2014 were included in this study. The MICs of antibiotics were determined using CLSI broth dilution method. The blaKec gene was amplified by polymerase chain reaction (PCR). Results A total of 205 CRKP strains were isolated, mainly from respiratory tract (76.1%, 156/205) and urine specimens (18.5%, 38/205). AntimicrobiaI susceptibility test indicated that CRKP isolates had higher resistance rates (85% - 100%) to the antimicrobial agents except colistin (1.5%), tigecycline (0.5%), trimethoprim-sulfamethoxazole (51.0%) and amikacin (74.9%). Most (87.8%, 180/205) of the CRKP strains were positive for blaKPC gene. Conclusions CRKP are mostly isolated from patients with lower respiratory tract infection and/or urinary tract infbction in Huashan Hospital. The strains were highly resistant to the antibacterial agents tested except colistin and tigecycline. Production ofKPC-type carbapenemase is the common mechanism of carbapenem resistance in these K. pneumoniae isolates.
出处 《中国感染与化疗杂志》 CAS CSCD 北大核心 2017年第3期298-302,共5页 Chinese Journal of Infection and Chemotherapy
关键词 碳青霉烯类耐药 肺炎克雷伯菌 敏感性 blaKPC基因 carbapenem-resistant Klebsiella pneumoniae antimicrobial susceptibility blaKPC gene
  • 相关文献

参考文献4

二级参考文献89

  • 1张婴元,朱德妹,胡付品,吴湜,汪复.1990—2004年上海地区临床分离大肠埃希菌耐药性变迁[J].中华医学杂志,2006,86(1):12-16. 被引量:34
  • 2骆俊,朱德妹,徐晓刚,吴卫红,王明贵,张婴元,汪复.泛耐药弗劳地柠檬酸杆菌产β内酰胺酶及同源性[J].中华传染病杂志,2006,24(5):291-295. 被引量:20
  • 3张嵘,蔡加昌,周宏伟,陈功祥.在一株弗劳地柠檬酸杆菌中发现KPC-2型碳青霉烯酶[J].中华检验医学杂志,2007,30(7):787-790. 被引量:7
  • 4Paukner S, Hesse L, Prezelj A, et al. In vitro activity of LK -157, a novel tricyclic carbapenem as broad spectrum beta lactamase inhibitor [J]. Antimicrob Agents Chemother, 2009, 53(2) : 505-511.
  • 5Petersen PJ, Jones CH, Venkatesan AM, et al. Efficacy of piperacillin combined with the penem beta-lactamase inhibitor BLI- 489 in murine models of systemic infection[J].Antimicrob Agents Chemother, 2009, 53(4): 1698-1700.
  • 6Endimiani A, Hujer KM, Hujer AM, et al. ACHN-490, a neoglycoside with potent in vitro activity against multidrugresistant Klebsiella pneumoniae isolates[J]. Antimicrob Agents Chemother, 2009, 53(10)4504-4507.
  • 7Lahey Clinic. Amino acid sequences for TEM, SHV and OXA extended spectrum and inhibitor-resistant β-lactamases. A-vailable from: URL[EB/OL]. http://www, lahey, org/ studies/webt, asp.
  • 8Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenemresistant strain of Klebsiella pneumoniae[J]. Antimicrob Agents Chemother, 2001 , 45(4) 1151-1161.
  • 9Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing: 19th informational supplement [S].CLSI/NCCLS M100 - S19. Clinical and Laboratory Standards Institute, Wayne, Penn sylvania.
  • 10Anderson KF, Lonsway DR, Rasheed JK, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae[J]. J Clin Microbiol, 2007, 45 (8) :2723-2725.

共引文献209

同被引文献175

引证文献18

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部